A New Variant of Alpha-1-Antitrypsin Deficiency (Siiyama) Associated with Pulmonary Emphysema

8Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

A 38-year-old male with pulmonary emphysema due to severely reduced serum alpha-1-antitrypsin (AAT) level (14.5 mg/dl) was found to have an inherited new AAT deficient variant Siiyama. Chest roentogenogram and CT scanning revealed advanced emphysema, and severe obstructive ventilatory impairment was observed. During the 4-year follow-up period, the annual rate of decline of FEV 1.0 showed approximately 10-fold greater than the normal decline in FEV 1.0 (-380ml/yr). Treatment with tamoxifen in order to raise the serum AAT level only resulted in an insufficient increase. Augmentation therapy of human AAT should be considered in the future. © 1992, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Takabe, K., Seyama, K., Shinada, H., Nouchi, T., Miyahara, Y., Nukiwa, T., … Marumo, F. (1992). A New Variant of Alpha-1-Antitrypsin Deficiency (Siiyama) Associated with Pulmonary Emphysema. Internal Medicine, 31(5), 702–707. https://doi.org/10.2169/internalmedicine.31.702

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free